To purchase hard copies of this book, please email:
orders@intechopen.com
Share this page
This book is indexed in
Medicine » Mental and Behavioural Disorders and Diseases of the Nervous System
Huntington's Disease - Core Concepts and Current Advances
Edited by Nagehan Ersoy Tunali, ISBN 978-953-307-953-0, Hard cover, 554 pages, Publisher: InTech, Chapters published February 15, 2012 under CC BY 3.0 license
DOI: 10.5772/1470
Huntington's Disease is one of the well-studied neurodegenerative conditions, a quite devastating and currently incurable one. It is a brain disorder that causes certain types of neurons to become damaged, causing various parts of the brain to deteriorate and lose their function. This results in uncontrolled movements, loss of intellectual capabilities and behavioural disturbances. Since the identification of the causative mutation, there have been many significant developments in understanding the cellular and molecular perturbations. This book, "Huntington's Disease - Core Concepts and Current Advances", was prepared to serve as a source of up-to-date information on a wide range of issues involved in Huntington's Disease. It will help the clinicians, health care providers, researchers, graduate students and life science readers to increase their understanding of the clinical correlates, genetic aspects, neuropathological findings, cellular and molecular events and potential therapeutic interventions involved in HD. The book not only serves reviewed fundamental information on the disease but also presents original research in several disciplines, which collectively provide comprehensive description of the key issues in the area.
- Chapter 1
Huntington’s Disease: From the Physiological Function of Huntingtin to the Disease - Chapter 2
Modeling Huntington’s Disease: in vivo, in vitro, in silico - Chapter 3
Molecular Mechanism of Huntington’s Disease — A Computational Perspective - Chapter 4
Biomarkers for Huntington’s Disease - Chapter 5
Quinolinate Accumulation in the Brains of the Quinolinate Phosphoribosyltransferase (QPRT) Knockout Mice - Chapter 6
Alterations in Expression and Function of Phosphodiesterases in Huntington’s Disease - Chapter 7
Cognition in Huntington's Disease - Chapter 8
Early Dysfunction of Neural Transmission and Cognitive Processing in Huntington’s Disease - Chapter 9
Endogenous Attention in Normal Elderly, Presymptomatic Huntington’s Disease and Huntington’s Disease Subjects - Chapter 10
Computational Investigations of Cognitive Impairment in Huntington's Disease - Chapter 11
Targeting Transcriptional Dysregulation in Huntington’s Disease: Description of Therapeutic Approaches - Chapter 12
ZNF395 (HDBP2 /PBF) is a Target Gene of Hif-1α - Chapter 13
Role of Huntington’s Disease Protein in Post-Transcriptional Gene Regulatory Pathways - Chapter 14
Energy Metabolism in Huntington’s Disease - Chapter 15
The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease - Chapter 16
Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways - Chapter 17
Cholesterol Metabolism in Huntington’s Disease - Chapter 18
Cellular Therapies for Huntington’s Disease - Chapter 19
Ameliorating Huntington's Disease by Targeting Huntingtin mRNA - Chapter 20
Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s Disease - Chapter 21
BDNF in Huntington’s Disease: Role in Pathogenesis and Treatment - Chapter 22
Risk and Resilience: Living with a Neurological Condition with a Focus on Health Care Communications - Chapter 23
Communication Between Huntington’s Disease Patients, Their Support Persons and the Dental Hygienist Using Talking Mats


